935-21983-27808
3 vaccinations
17 coded responses
39 check-ins
17 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Survey response — day 0, dose 1MedDRA: No adverse event — Feeling: Good · Site: PainFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · Chills, Muscle or body aches, Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — day 7, dose 1MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-04-23
-
2021-04-27
Dose 2 — Pfizer-BioNTech
-
2021-04-27
Survey response — day 0, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-28
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Good · Headache, Fatigue or tirednessFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-01
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-04
Survey response — day 7, dose 2MedDRA: No adverse event — Feeling: Good · HeadacheFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
- 2021-05-25
-
2021-06-01
Survey response — day 35, dose 2MedDRA: Abdominal pain, Diarrhoea — Feeling: GoodFree text: Abdominal pain with infrequent diarrhea x 4 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-08
- 2021-07-27
- 2021-10-26
-
2021-11-01
Dose 3 — Pfizer-BioNTech
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-15
- 2022-01-31
- 2022-05-02
-
2022-11-01
Survey response — 12 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-27 | Pfizer-BioNTech | |
| 3 | 2021-11-01 | Pfizer-BioNTech | No |
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): No
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): No
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 7 — day 7, dose 1
Systemic reaction (other): No
Release 8 — day 0, dose 2
Systemic reaction (other): No
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Systemic reaction (other): No
Release 8 — day 7, dose 2
Systemic reaction (other): No
Release 8 — day 35, dose 2
Symptoms: Abdominal pain with infrequent diarrhea x 4 days
Release 12 — 12 months, dose 3
Symptoms: Upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release